Lyra Therapeutics Inc (NAS:LYRA)
$ 0.2952 -0.0149 (-4.8%) Market Cap: 18.00 Mil Enterprise Value: -31.26 Mil PE Ratio: 0 PB Ratio: 0.23 GF Score: 29/100

Lyra Therapeutics Inc in Maria Palasis & Strong Leadership in HealthTech Transcript

Oct 08, 2020 / NTS GMT
Release Date Price: $11.43 (+2.97%)
Joe Mullings
The Mullings Group Companies - Moderator

Joe Mullings from One60 Studios in Delray Beach, Florida. I am sitting this morning with Maria Palasis, who is the President and Chief Executive Officer of Lyra Therapeutics, and she's joining us from Boston. Thanks for taking part of this this morning.

Maria Palasis
Lyra Therapeutics, Inc. - President, CEO, Director

Thank you, Joe. It's my pleasure.

Joe Mullings
The Mullings Group Companies - Moderator

Yeah, and we're getting together around the AdvaMed Conference happening up in -- well, I want to say up in Canada or Boston, but virtual this year. So that's been a bit of a change for everybody.

Maria Palasis
Lyra Therapeutics, Inc. - President, CEO, Director

Yeah.

Joe Mullings
The Mullings Group Companies - Moderator

Lyra, you head up. Lyra Therapeutics, and recently you took that organization public in the very early days of the COVID pandemic up in Boston. And I had

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot